When science and politics collide: Support for enhancing FDA independence

May 16, 2019

PROVIDENCE, R.I. [Brown University] -- Earlier this year, twin papers authored by seven former Food and Drug Administration commissioners, published by Health Affairs and the Aspen Institute on the same day, suggested that the FDA should become an independent agency.

A new paper by Eli Y. Adashi, Rohit Rajan, and I. Glenn Cohen appears in Science this week and picks up where those papers left off. Adashi, Rajan, and Cohen write that the crucial mission of the FDA, which has been to make science-based decisions about drug and medical device safety since 1938, has recently been undermined and threatened by politically motivated interference from congressional legislators.

In some ways, the FDA has been vulnerable to politicization from both sides of the aisle since the mid-1960s, resulting in a slow but steady loss of independence. However, write Adashi, Rajan, and Cohen, there has been a recent uptick in political influence on the FDA's decisions, including the recent Plan B debacle. In the long run, the American people are at risk of losing the independent drug safety watchdog they rely on.

While the FDA will never be truly free from political pressure, Adashi, Rajan, and Cohen support the move for a more independent version of the agency, and also suggest some safeguards, which will allow the agency to stay true to its mission. "The hope is, that when values clash, an independent FDA will navigate the conflict with the nation's best interest in mind," they write. Their suggestions include: a six-year term for FDA commissioners, budgetary independence modelled on the Federal Communications Commission (another independent agency), and rule-making authority with selective oversight by the Office of Information and Regulatory Affairs and Office of Management and Budget.

"The fate and stature of the FDA rest in the hands of lawmakers who may be reluctant to alter the status quo for fear of losing leverage," write Adashi, Rajan, and Cohen. "Failure to codify in law the independence of the FDA now or in the near future must be viewed as an opportunity missed."

Unless FDA's independence is protected, and science allowed to reign supreme, the effectiveness of the FDA could fall by the wayside in favor of politically motivated compromise.
About Brown University

Founded in 1764, Brown University is an independent, coeducational Ivy League institution and the seventh-oldest college in the U.S. Brown is a leading research university where talented students and accomplished faculty collaborate to blend deep content knowledge to address the defining challenges of a complex and changing world. At the heart of the University's teaching, research and scholarship is a commitment to academic excellence, intellectual freedom and making an impact to better serve people, communities and society.

About the Petrie-Flom Center

The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School is a leading research program dedicated to the unbiased legal and ethical analysis of pressing questions facing health policymakers, medical professionals, patients, families, and others who influence and are influenced by health care and the health care system.

Brown University

Related Decisions Articles from Brightsurf:

Consumers value difficult decisions over easy choices
In a paper co-authored by Gaurav Jain, an assistant professor of marketing in the Lally School of Management at Rensselaer, researchers found that disfluency, or the difficulty for an individual to process a message, increases people's attitudes toward that message after a time delay.

Evolutionary theory of economic decisions
When survival over generations is the end game, researchers say it makes sense to undervalue long shots that could be profitable and overestimate the likelihood of rare bad outcomes.

Decisions made for incapacitated patients often not what families want
Researchers from Regenstrief Institute and Indiana University report in a study published in JAMA Network Open that nearly half of the time medical treatments and orders received for incapacitated patients were not compatible with goals of care requested by their surrogate decision makers.

Which COVID-19 models should we use to make policy decisions?
A new process to harness multiple disease models for outbreak management has been developed by an international team of researchers.

For complex decisions, narrow them down to two
When choosing between multiple alternatives, people usually focus their attention on the two most promising options.

Fungal decisions can affect climate
Research shows fungi may slow climate change by storing more carbon.

How decisions unfold in a zebrafish brain
Researchers were able to track the activity of each neuron in the entire brain of zebrafish larvae and reconstruct the unfolding of neuronal events as the animals repeatedly made 'left or right' choices in a behavioral experiment.

Best of the best: Who makes the most accurate decisions in expert groups?
New method predicts accuracy on the basis of similarity.

How do brains remember decisions?
Mammal brains -- including those of humans -- store and recall impressive amounts of information based on our good and bad decisions and interactions in an ever-changing world.

How we make complex decisions
MIT neuroscientists have identified a brain circuit that helps break complex decisions down into smaller pieces.

Read More: Decisions News and Decisions Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.